| Monday, October 29, 2007 | ||
| 7:15 a.m. - 8:45 a.m. | Educational Session 201 Concourse Hall Breast Cancer Management |
Douglas W. Arthur, M.D., Virginia Commonwealth University, Richmond,Va. Bruce G. Haffty, M.D., UMDNJ-Robert Wood Johnson Medical School, New Brunswick, N.J. |
| 7:15 a.m. - 8:45 a.m. | Educational Session 202 Room 501 Intra Cranial SRS Benign/Malignant Tumors and Functional Disorders |
Jay S. Loeffler, M.D., Massachusetts General Hospital, Boston Arnab Chakravarti, M.D., Massachusetts General Hospital, Boston Jason P. Sheehan, M.D., Ph.D.,University of Virginia School of Medicine, Charlottesville, Va. |
| 7:15 a.m. - 8:45 a.m. | Educational Session 203 Room 511 Interactions of Radiation with Novel Chemotherapy and Biological Targeting Agents |
Kevin A. Camphausen, M.D., National Cancer Institute/NIH, Bethesda, Md. George D. Wilson, Ph.D., William Beaumont Hospital, Royal Oak, Mich. Paul M. Harari, M.D., University of Wisconsin Cancer Center, Madison, Wis. |
| 7:15 a.m. - 8:45 a.m. | Educational Session 204 Room 409 Controversies in the Management of Endometrial Cancer |
Steven C. Plaxe, M.D., University of California, San Diego, San Diego Arno J. Mundt, M.D., University of California San Diego, San Diego |
| 7:15 a.m. - 8:45 a.m. | Educational Session 205 Interative Session Room 403 Challenging Lung Cancer Cases: Neuroendocrine/Small Cell Lung Cancer |
David S. Ettinger, M.D., Kimmel Cancer Center at Johns Hopkins, Baltimore Paul A. Kvale, M.D., Benjamin Movsas, M.D., Henry Ford Hospital, Detroit Branislav Jeremic, M.D., Ph.D., Walter Scott, M.D., |
| 7:15 a.m. - 8:45 a.m. | Educational Session 206 |
Anthony V. D'Amico, M.D., Ph.D., Andrew K. Lee, M.D., M.P.H., |
| 7:15 a.m. - 8:45 a.m. | Educational Session 207 Room 408 Transitioning from 3-D IMRT to 4-D IMRT and Role of Image-guidance |
Ping Xia, Ph.D., Jatinder Palta, Ph.D., University of Florida/Davis Cancer Center, Gainesville, Fla. |
| 7:15 a.m. - 8:45 a.m. | Educational Session 208 Room 405 Molecular Mechanisms of DNA Damage and Repair |
Kathryn D. Held, Ph.D., Massachusetts General Hospital, Boston Brendan D. Price, Ph.D., Dana-Farber Cancer Institute, Boston |
| 7:15 a.m. - 8:45 a.m. | Educational Session 209 Room 407 Radiolabeld Monoclonal Antibodies |
Susan J. Knox, Ph.D., M.D., The Center for Advanced Medicine, Stanford University, Stanford, Calif. |
| 7:15 a.m. - 8:45 a.m. | Educational Session 210 Room 404 History of Radiation Oncology: Brachytherapy |
Martin Colman, M.D., Gustavo S. Montana, M.D., Roger Frank Robison, M.D., Herman D. Suit, M.D., D.Phil., J. Frank Wilson, M.D., FASTRO, Jesse N. Aronowitz, M.D., |
| 9:00 a.m.- 10:00 a.m. | Keynote Speaker |
|
| Introduction: | Steven A. Leibel, M.D., Stanford Cancer Center, Stanford, Calif. | |
| Better Than Band-Aids: America Needs Comprehensive Health Care Reform | Ezekiel J. Emanuel, M.D., Ph.D. |
|
| 10:15 a.m. - 11:45 a.m. | Poster Discussion 1 Room 515B Breast – Advances in Breast Radiation Techniques |
Co-moderators: Silvia Chiara Formenti Abram Recht |
| 10:15 a.m. - 11:45 a.m. | Poster Discussion 2 Room 518 Experimental Therapeutics |
Co-moderators: Kevin Camphausen Bo Lu |
| 10:15 a.m. - 11:45 a.m. |
Scientific Session A Room 515A Clinical Trials |
Co-moderators: Stephen Hahn Lynn Wilson |
| 10:15 a.m. 7 - Prophylactic Cranial Irradiation (PCI) in Extensive Stage Small Cell Lung Cancer (ES-SCLC) (EORTC 22993-08993) |
B. Slotman | |
| 10:25 a.m. 8 - Differences between African American (AA) and Caucasian (C) Patients Treated with Conservative Surgery and Radiation Therapy (CS+RT) for Early Stage Breast Cancer |
Meena Moran | |
| 10:35 a.m. 9 - Concomitant Radio-chemotherapy (CT-RT) versus Sequential CT-RT In Locally Advanced Non-small Cell Lung Cancer (NSCLC): A Meta-analysis using Individual Patient Data (IPD) from Randomised Clinical Trials (RCTs) |
Walter Curran |
|
| 10:45 a.m. 10 - Extended Field Irradiation and Intracavitary Brachytherapy Combined with Cisplatin Chemotherapy for Cervical Cancer with Positive Para-aortic or High Common Iliac Lymph Nodes: Results of Arm 2 of RTOG 0116 |
William Small | |
| 10:55 a.m. 137 - Post-resectional CA 19-9 Values > 90 are Associated with Significantly Worse Survival in Patients with Pancreatic Carcinoma Treated with Adjuvant Therapy on RTOG 9704 - Implications for Current and Future Trials |
William Regine | |
| 10:15 a.m. - 11:45 a.m. | Scientific Session B Room 502 GU I - Late Toxicity After Treatment for Prostate Cancer |
Co-moderators: |
| 11 - Gene Profile Highlights Late Rectal Bleeding Protection in Prostate Cancer 3D Conformal Radiation | Riccardo Valdagni | |
| 12 - Single Nucleotide Polymorphisms as Predictors for Development of Erectile Dysfunction in African-american Men Treated with Radiotherapy for Prostate Cancer | Julian Moore | |
| Discussant: Jeff Michalski |
||
| 13 - A Comparison of Sexual Function Following Radiotherapy for Prostate Cancer: Results of a Prospective, Randomized Trial of Hypofractionated Intensity Modulated Radiotherapy | Mark Buyyounouski | |
| 14 - Late Pelvic Toxicity following Bladder-sparing Therapy in Patients with Invasive Bladder Cancer: Analysis of RTOG 89-03, 95-06, 97-06, 99-06 |
William Shipley | |
| 15 - Fit of a Generalized Lyman Normal-tissue Complication Probability (NTCP) Model to Grade > 2 Late Rectal Toxicity Data from Patients Treated on Protocol RTOG 94-06 | Susan Tucker | |
| 16 - Dose-volume Analyses of Grade > 2 Late Rectal Toxicity among Patients Treated on Protocol RTOG 94-06 | M. Cheung | |
| 17 - Intensity Modulated Radiation Therapy Reduces Gastrointestinal Morbidity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer | Navesh Sharma | |
| 18 - Spatial and Anatomical Indicators of Rectal Toxicity in IMRT of Prostate Cancer | Reshma Munbodh | |
| 10:15 a.m. - 11:45 a.m. | Scientific Session C |
Co-moderators: David Brizel Madhur Garg |
| 19 - Mitomycin-C and 5-Fluoro-Uracil containing Chemotherapy with Concurrent Hyperfractionated Accelerated RadioTherapy (C-HART) of 70.6 Gy is more Effective than Dose Escalated HART of 77.6 Gy alone - 10 Year Results of the German Multicenter Phase III Random | Volker Budach | |
| 20 - Hyperfractionated Radiotherapy versus Hyperfractionated Radiotherapy and Concomitant Chemotherapy in Locally Advanced Head and Neck Cancer | Mohit Kasibhatla | |
| 21 - A Phase III Trial to Compare Standard versus Accelerated Fractionation in Combination with Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Report of Compliance and Toxicity | K. Kian Ang | |
| 22 - Phase II Randomized Trial of Surgery Followed by Chemoradiation Plus Cetuximab for High-risk Squamous Cell Carcinoma of the Head and Neck (RTOG 0234) | Paul Harari | |
| |
Discussant: Robert Amdur |
|
23 - Phase II Multi-institutional Study of IMRT +/- Chemotherapy for Nasopharyngeal Carcinoma (RTOG 0225): Preliminary Results |
Nancy Lee | |
| 24 - FDG PET Accuracy in Assessment of Treatment Response in Head and Neck Cancer after Intensity Modulated Radiotherapy - Long-term Outcome Report | Min Yao | |
| 25 - Lymph Node-positive Head and Neck Cancer Treated with Primary Radiotherapy: Can Treatment Response Determine the Extent of Neck Dissection? | Anamaria Yeung | |
| 26 - Can Adjuvant Neck Dissection be Deferred in Locally Advanced Head and Neck Cancer Patients with Complete Response to Definitive Chemoradiotherapy? | Susannah Yovino | |
| 10:15 a.m. - 11:45 a.m. | Scientific Session D The Theater Lymphoma |
Moderator: |
| 27 - Increased Overall Survival in Patients with Stages I and II Diffuse Large B-Cell Lymphoma Treated with Radiation Therapy: A Surveillance, Epidemiology and End Results (SEER) Analysis | Rachel Rabinovitch | |
| 28 - Decreased Incidence of Cardiac Mortality in Patients with Stages I and II Diffuse Large B-Cell Lymphoma Treated with Radiation: A Surveillance, Epidemiology, and End-results (SEER) Analysis | Thomas Pugh | |
| 29 - Reduced Acute Toxicities with Image Guided Targeted Marrow Irradiation (TMI) using Helical TomoTherapy (HT) in Patients with Multiple Myeloma and Acute Leukemia Undergoing Hematopoietic Cell Transplantation (HCT) | Jeffrey Wong | |
| 30 - Lung Blocking for Total Body Irradiation: Effect on Pulmonary Function Test Changes | Carolyn Rutter | |
| 31 - A Non-stanford Mature Experience with Stanford V ± RT Regimen for Locally Extensive and Advanced Hodgkin Lymphoma (HL) | Sophia Edwards-Bennett | |
| Discussants: Andrea Ng Lena Specht |
||
| 10:15 a.m. - 11:45 a.m. | Scientific Session E |
Co-moderators: Nesrin Dogan David Jaffray |
| 32 - Investigations in the Design of a Novel Linac-MRI System | Gino Fallone | |
| 33 - Adaptive Field Aperture Modification for the Management of Patient Setup Errors | Mohammad Islam | |
34 - Quality Control for Image Guided Adaptive Radiotherapy of Prostate Cancer |
Jennifer Wloch | |
| 35 - On-line Adaptive Planning System for Prostate IMRT Treatment | Danthai Thongphiew | |
| 36 - Improved Target Localization with 3D Cone Beam CT On-board Imaging in Stereotactic Body Radiation Therapy | John Kirkpatrick | |
| 37 - Are Pre and Post Imaging Sufficient to Assess Intrafraction Prostate Motion? | Camille Noel | |
| 38 - An On-line Adaptive Planning Strategy for Inter-fraction Image Guidance | Ergun Ahunbay | |
| 39 - Dosimetric Consequences of Intrafraction Prostate Motion on Patients Enrolled on Multi-institutional Hypofractionation Study | Beth Pierburg | |
| 40 - Predictive Adaptive Radiation Therapy for Lung Cancer | Chester Ramsey | |
| 10:15 a.m. - 11:45 a.m. | Educational Session 211 Room 409 Normal Tissue Tolerances in Clinical Practice |
Soren M. Bentzen, Ph.D., D.Sc., University of Wisconsin Medical School, Madison, Wisc. Louis S. Constine, M.D., University of Rochester Medical Center, Rochester, N.Y. Joseph O. Deasy, Ph.D., Washington University School of Medicine, St. Louis Lawrence B. Marks, M.D., Duke University Medical Center, Durham, N.C. Randall K. Ten Haken, Ph.D., University of Michigan, Ann Arbor, Mich. |
| 10:15 a.m. - 11:45 a.m. | Educational Session 212 Room 511 Stereotactic Body RT: Clinical and Biological Perspectives |
Brian Kavanagh, M.D., University of Colorado Health Sciences Center, Aurora, Colo. Robert D. Timmerman, M.D., University of Texas Southwestern, Dallas, Texas Stanley H. Benedict, Ph.D., University of Virginia Health Systems, Charlottesville, Va. |
| 11:45 a.m. - 1:15 p.m. | Socioeconomic Lunch | |
| 11:45 a.m. - 1:15 p.m. | ARRO Poster Walk | |
| 11:45 a.m. - 1:15 p.m. | MITA- NEMA Code of Ethics | |
| 1:15 p.m.- 1:45 p.m. | Presidential Address |
|
| Introduction | Zvi Fuks, M.D., Memorial Sloan-Kettering Cancer Center, New York |
|
| Thoughts About Image, Substance and Adaptation- What Radiation Oncology Can Learn From Hollywood | Louis B. Harrison, M.D., Continuum Cancer Centers of New York, Beth Israel Medical Center, St. Luke’s and Roosevelt Hospitals and The New York Eye and Ear Infirmary, Albert Einstein College of Medicine, New York | |
| 1:30 p.m. - 3:00 p.m. | Nurses Session 11 Room 501 Proton Therapy |
Ray Lin, M.D., Scripps Health, La Jolla, Calif. Elizabeth Brunton, R.N., M.S.N., O.C.N., Scripps Health, La Jolla, Calif. Yolanda Magana, R.N., B.S.N., M.B.A., Loma Linda University Medical Center, Loma Linda, Calif. Julihana Madison, R.N., B.S.N., Loma Linda University Medical Center, Loma Linda, Calif. |
| 2:00 p.m. - 3:30 p.m. | Plenary Session Interactive Concourse Hall |
|
| 3:15 p.m. - 4:15 p.m. | Nurses Session 12 Room 504 Depression & the Oncology Patient: Increased Distress, Decreased Coping |
Belinda Anderson, R.N., M.S.N, M.B.A., Overton Brooks Medical Center, Shreveport, La. |
| 3:15 p.m. - 4:15 p.m. | Nurses Session 13 Room 505 PCI for Brain Mets |
Pamela Devine, R.N., B.S.N., M.S.N., Philadelphia Veteran Administration Hospital, Philadelphia |
| 3:15 p.m. - 4:15 p.m. | Nurses Session 14 Room 503 Infection Control: MRSA and Other Infections: Caring for Our Patients and Staff |
Bonnie Wivell, R.N., B.S.N., O.C.N., Lakewood, Colo. |
| 3:45 p.m. - 5:15 p.m. | Educational Session 213 The Theater Brachytherapy for Gyn Neoplasms: (HDR and LDR) |
Patricia J. Eifel, M.D., M.D. Anderson Cancer Center, Houston Akila N. Viswanathan, M.D., M.P.H., Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston |
| 3:45 p.m. - 5:15 p.m. | Educational Session 214 Interactive Session Room 511 Case Presentations in Hodgkin's Disease and Lymphoma |
Mary Gospodarowicz, M.D., Princess Margaret Hospital, Toronto, Ontario, Canada Richard T. Hoppe, M.D., Stanford University, Stanford, Calif. Andrew Zelenetz, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center, New York Peter M. Mauch, M.D., Brigham and Women's Hospital, Boston Joachim Yahalom, M.D., Memorial Sloan-Kettering Cancer Center, New York |
| 3:45 p.m. - 5:15 p.m. | Panel 06 Room 403 Perspectives in Surgical Oncology Advances in Surgical Oncology are often important to the Radiation Oncologist, as well, working hand-in-hand toward the regional management of cancer. After participating in this session, attendees should be familiar with past and current contributions of Surgical Oncology, i.e., the century old background of pathologic data supporting the use of neo-adjuvant therapy in rectal cancer, should be aware of surgical advances in performing total mesorectal excision intended to minimize operative morbidity, should be familiar with methods of achieving trans-hiatal esophagectomy with minimal morbidity, should be familiar with the evolving role of minimally invasive diagnosis and surgery for breast cancer and with the advances in VATS lobectomy for reducing the morbidity of lung cancer resection. |
Moderator: Warren E. Enker, M.D., Beth Israel Medical Center, New York Thomas E. Read, M.D., Western Pennsylvania Hospital, Temple University School of Medicine, Pittsburgh Andrew C. Chang, M.D., University of Michigan, Ann Arbor, Mich Sheldon Feldman, M.D., Beth Israel Medical Center, New York Scott Swanson, M.D., Mount Sinai Medical Center, New York Eugene W. Friedman, M.D., Mount Sinai School of Medicine, New York |
| 3:45 p.m. - 5:15 p.m. | Panel 07
Room 502 The Rush to IMRT : Are We Overlooking the
Ob vious? |
Moderator: Theodore L. DeWeese, M.D., Johns Hopkins University School of Medicine, Baltimore John W. Wong, Ph.D., Johns Hopkins University School of Medicine, Baltimore Brian Marples, Ph.D., Mohan Suntha, M.D., University of Maryland Medical Center, Baltimore |
| 3:45 p.m. - 5:15 p.m. | Panel 08 Interactive Concourse Hall On Board Imaging: Challenges and Future Directions |
Moderator: Mack Roach III, M.D., University of California, San Francisco Fang-Fang Yin, Ph.D., Duke University, Durham, N.C. Patrick Kupelian, M.D., M.D. Anderson Cancer Center – Orlando, Orlando, Fla. Jean Pouliott, Ph.D., University of California, San Francisco Mack Roach III, M.D., University of California, San Francisco |
| 3:45 p.m. - 5:15 p.m. | Panel 09 Room 408 Pancreas Cancer |
Moderator: Ross A. Abrams, M.D., Rush University, Chicago Christi Iacobuzio-Donahue, M.D., Ph.D., Johns Hopkins University School of Medicine, Baltimore Vincent J. Picozzi Jr, MD, Virginia Mason, Seattle, Wash. |
| 3:45 p.m. - 5:15 p.m. | Panel 10 A major challenge for individual or group practices involved in Quality Improvement projects is the effort required in obtaining the data. This panel will discuss software data mining of the treatment systems/data already in use for efficiency or quality purposes. |
Moderator: Peter A.S. Johnstone, M.D., Emory University, Atlanta Larry E. Kun, M.D., St. Jude Children’s Research Hospital, Memphis, Tenn. Christopher M. Rose, M.D., Valley Radiological Associates, Los Angeles, Calif. Eliot Levitt, Valley Radiological Associates, Los Angeles, Calif. Timothy Fox, Ph.D., Emory University, Atlanta |
| 4:30 p.m. - 5:30 p.m. | Nurses Session 15 Room 501 Lung Cancer "What are we doing"? |
Michelle Phelan, A.C.N.P., A.O.C.N., Overton Brooks Medical Center, Shreveport, La. |
| 4:30 p.m. - 5:30 p.m. | Nurses Session 16 Room 505 Complementary Therapies Used by Cancer Patients: Herbals, Praying, Yoga, and Healers |
James M. Metz, M.D., University of Pennsylvania Medical Center, Philadelphia |
| 4:30 p.m. - 5:30 p.m. | Nurses Session 17 Room 504 Hospice: Caring for the Patient Across the Continuum |
Linda Filipczak, R.N., B.S.N., M.B.A., 21st Century Oncology, Plymouth, Mich. |
| 5:00 p.m. - 6:30 p.m. | NCI/ASTRO Cancer Disparity Symposium/Reception- Accrual Strategies to Clinical Trials Location TBD Don’t miss this unique opportunity to learn more about the accrual strategies to cancer clinical trials from these two experts. Session will identify strategies to use with different cancer populations to recruit to clinical trials thereby bringing the benefits of clinical research to disparity communities. |
David G. Brachman M.D., St. Josephs Hospital/Barrow Neurological Institute, and Vice President, Arizona Oncology Services and Foundation, Phoenix. William J. Hicks, M.D., James Cancer Hospital, Ohio State University, Columbus, Ohio |
| 5:30 p.m. - 6:15 p.m. | What's Happening in Radiation Therapy Reimbursement - Future Trends Millennium Biltmore Hotel Emerald Room Policymakers responsible for reforming the Medicare program to achieve long term stability are focusing on providing physicians with individualized reports on both the quality and efficiency of the care they provide. Learn more about this new trend and how it may impact your bottom line. |
|
Additional information will be posted periodically. Inquiries should be directed the Education Department.